Physician
John William Adams, DO
According to 2025 Medicare claims, John Adams, DO (NPI: 1548262900) practices medical oncology in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Tarrant, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1033386578; TIN: 752131429) and primary practice location at 76012-2510. Adams is affiliated with the UT Southwestern Accountable Care Network (ACO ID: D0211), participating under the REACH model.
Adams' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 352 traditional Medicare patients, billed 89,608 HCPCS/CPT codes, and received $1,514,625 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,126 prescription claims across 175 beneficiaries totaling $2,020,322 in drug costs, led by Calquence (Acalabrutinib Maleate). DME data shows 25 claims. Open Payments data shows 20 records totaling $6,630. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $145,558 to $1,514,625. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $718,580 and ending at $2,020,322. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $5,372 to $1,120.